Chapter 9 Regulation of Human Dihydrofolate Reductase Activity and Expression

Vitamins and Hormones

Volumn 79, Issue , 2008, Pages 267-292

  Abali, Emine Ercikan ^a   Skacel, Nancy E ^a   Celikkaya, Hilal ^a   Hsieh, Yi Ching ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROFOLATE REDUCTASE; FOLIC ACID ANTAGONIST;

CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PROTEIN CONFORMATION; REVIEW;

FOLIC ACID ANTAGONISTS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MOLECULAR STRUCTURE; PROTEIN CONFORMATION; TETRAHYDROFOLATE DEHYDROGENASE;

EID: 51849098889     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0083-6729(08)00409-3     Document Type: Review

References (102)

1. Abelson H.T., Spector R., Gorka C., and Fosburg M. Kinetics of tetrahydrobiopterin synthesis by rabbit brain dihydrofolate reductase. Biochem. J. 171 (1978) 267-268
2. Adams M., Lucock M., Stuart J., Fardell S., Baker K., and Ng X. Preliminary evidence for involvement of the folate gene polymorphism 19 bp deletion-DHFR in occurrence of autism. Neurosci. Lett. 422 (2007) 24-29
3. Anagnou N.P., O'Brien S.J., Shimada T., Nash W.G., Chen M.J., and Nienhuis A.W. Chromosomal organization of the human dihydrofolate reductase genes: Dispersion, selective amplification, and a novel form of polymorphism. Proc. Natl. Acad. Sci. USA 81 16 (1984) 5170-5174
4. Anagnou N.P., Antonarakis S.E., O'Brien S.J., Modi W.S., and Nienhuis A.W. Chromosomal localization and racial distribution of the polymorphic human dihydrofolate reductase pseudogene (DHFRP1). Am. J. Hum. Genet. 42 (1988) 345-352
5. Appleman J.R., Prendergast N., Delcamp T.J., Freisheim J.H., and Blakley R.L. Kinetics of the formation and isomerization of methotrexate complexes of recombinant human dihydrofolate reductase. J. Biol. Chem. 263 (1988) 10304-10313
6. Azizkhan J.C., Vaughn J.P., Christy R.J., and Hamlin J.L. Nucleotide sequence and nuclease hypersensitivity of the Chinese hamster dihydrofolate reductase gene promoter region. Biochemistry 25 (1986) 6228-6236
7. Azizkhan J.C., Jensen D.E., Pierce A.J., and Wade M. Transcription from TATA-less promoters: Dihydrofolate reductase as a model. Crit. Rev. Eukaryot. Gene Expr. 3 (1993) 229-254
8. Banerjee D., Schnieders B., Fu J.Z., Adhikari D., Zhao S.C., and Bertino J.R. Role of E2F-1 in chemosensitivity. Cancer Res. 58 (1998) 4292-4296
9. Banerjee D., Gorlick R., Liefshitz A., Danenberg K., Danenberg P.C., Danenberg P.V., Klimstra D., Jhanwar S., Cordon-Cardo C., Fong Y., Kemeny N., and Bertino J.R. Levels of E2F-1 expression are higher in lung metastasis of colon cancer as compared with hepatic metastasis and correlate with levels of thymidylate synthase. Cancer Res. 60 (2000) 2365-2367
10. Banerjee D., Mayer-Kuckuk P., Capiaux G., Budak-Alpdogan T., Gorlick R., and Bertino J.R. Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase. Biochim. Biophys. Acta 1587 (2002) 164-173
11. Bastow K.F., Prabhu R., and Cheng Y.C. The intracellular content of dihydrofolate reductase: Possibilities for control and implications for chemotherapy. Adv. Enzyme Regul. 22 (1984) 15-26
12. Benkovic S.J., and Hammes-Schiffer S. A perspective on enzyme catalysis. Science 301 (2003) 1196-1202
13. Bertino J.R., Donohue D.R., Gabrio B.W., Silber R., Alenty A., Meyer M., and Huennekens F.M. Increased level of dihydrofolic reductase in leucocytes of patients treated with amethopterin. Nature 193 (1962) 140-142
14. Bertino J.R., Donohue D.M., Simmons B., Gabrio B.W., Silber R., and Huennekens F.M. The "induction" of dihydrofolic reductase activity in leukocytes and erythrocytes of patients treated with amethopterin. J. Clin. Invest. 42 (1963) 466-475
15. Bertino J.R., Cashmore A.R., and Hillcoat B.L. "Induction" of dihydrofolate reductase: Purification and properties of the "induced" human erythrocyte and leukocyte enzyme and normal bone marrow enzyme. Cancer Res. 30 (1970) 2372-2378
16. Black A.R., Jensen D., Lin S.Y., and Azizkhan J.C. Growth/cell cycle regulation of Sp1 phosphorylation. J. Biol. Chem. 274 (1999) 1207-1215
17. Blakley R.L. Eukaryotic dihydrofolate reductase. Adv. Enzymol. Relat. Areas Mol. Biol. 70 (1995) 23-102
18. Blakley R.L., and Cocco L. Dismutation of dihydrofolate by dihydrofolate reductase. Biochemistry 23 (1984) 2377-2383
19. Blakley R.L., and Sorrentino B.P. In vitro mutations in dihydrofolate reductase that confer resistance to methotrexate: Potential for clinical application. Hum. Mutat. 11 (1998) 259-263
20. Blume S.W., Meng Z., Shrestha K., Snyder R.C., and Emanuel P.D. The 5′-untranslated RNA of the human dhfr minor transcript alters transcription pre-initiation complex assembly at the major (core) promoter. J. Cell. Biochem. 88 (2003) 165-180
21. Botto L.D., and Yang Q. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: A HuGE review. Am. J. Epidemiol. 151 (2000) 862-877
22. Bottoms C.A., Smith P.E., and Tanner J.J. A structurally conserved water molecule in Rossmann dinucleotide-binding domains. Protein Sci. 11 (2002) 2125-2137
23. Bystroff C., and Kraut J. Crystal structure of unliganded Escherichia coli dihydrofolate reductase. Ligand-induced conformational changes and cooperativity in binding. Biochemistry 30 (1991) 2227-2239
24. Carugo O., and Argos P. NADP-dependent enzymes. I: Conserved stereochemistry of cofactor binding. Proteins 28 (1997) 10-28
25. Carugo O., and Argos P. NADP-dependent enzymes. II: Evolution of the mono- and dinucleotide binding domains. Proteins 28 (1997) 29-40
26. Chalupsky K., and Cai H. Endothelial dihydrofolate reductase: Critical for nitric oxide bioavailability and role in angiotensin II uncoupling of endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. USA 102 (2005) 9056-9061
27. Chang Y.C., Illenye S., and Heintz N.H. Cooperation of E2F-p130 and Sp1-pRb complexes in repression of the Chinese hamster dhfr gene. Mol. Cell. Biol. 21 (2001) 1121-1131
28. Chen M.J., Shimada T., Moulton A.D., Harrison M., and Nienhuis A.W. Intronless human dihydrofolate reductase genes are derived from processed RNA molecules. Proc. Natl. Acad. Sci. USA 79 (1982) 7435-7439
29. Chen M.J., Shimada T., Moulton A.D., Cline A., Humphries R.K., Maizel J., and Nienhuis A.W. The functional human dihydrofolate reductase gene. J. Biol. Chem. 259 (1984) 3933-3943
30. Chu E., Takimoto C.H., Voeller D., Grem J.L., and Allegra C.J. Specific binding of human dihydrofolate reductase protein to dihydrofolate reductase messenger RNA in vitro. Biochemistry 32 (1993) 4756-4760
31. Cody V., and Schwalbe C.H. Structural characteristics of antifolate dihydrofolate reductase enzyme interactions. Crystallogr. Rev. 12 (2006) 301-333
32. Cody V., Luft J.R., Ciszak E., Kalman T.I., and Freisheim J.H. Crystal structure determination at 2.3 A of recombinant human dihydrofolate reductase ternary complex with NADPH and methotrexate-gamma-tetrazole. Anticancer Drug Des. 7 (1992) 483-491
33. Cody V., Galitsky N., Luft J.R., Pangborn W., Blakley R.L., and Gangjee A. Comparison of ternary crystal complexes of F31 variants of human dihydrofolate reductase with NADPH and a classical antitumor furopyrimidine. Anticancer Drug Des. 13 (1998) 307-315
34. Cowan K.H., Goldsmith M.E., Ricciardone M.D., Levine R., Rubalcaba E., and Jolivet J. Regulation of dihydrofolate reductase in human breast cancer cells and in mutant hamster cells transfected with a human dihydrofolate reductase minigene. Mol. Pharmacol. 30 (1986) 69-76
35. Czeizel A.E., and Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N. Engl. J. Med. 327 (1992) 1832-1835
36. Davies II J.F., Delcamp T.J., Prendergast N.J., Ashford V.A., Freisheim J.H., and Kraut J. Crystal structures of recombinant human dihydrofolate reductase complexed with folate and 5-deazafolate. Biochemistry 29 (1990) 9467-9479
37. Doetzlhofer A., Rotheneder H., Lagger G., Koranda M., Kurtev V., Brosch G., Wintersberger E., and Seiser C. Histone deacetylase 1 can repress transcription by binding to Sp1. Mol. Cell. Biol. 19 (1999) 5504-5511
38. Domin B.A., Grill S.P., Bastow K.F., and Cheng Y.C. Effect of methotrexate on dihydrofolate reductase activity in methotrexate-resistant human KB cells. Mol. Pharmacol. 21 (1982) 478-482
39. Ercikan E., Banerjee D., Waltham M., Schnieders B., Scotto K.W., and Bertino J.R. Translational regulation of the synthesis of dihydrofolate reductase. Adv. Exp. Med. Biol. 338 (1993) 537-540
40. Ercikan E., Waltham M., Dicker A., Schweitzer B., and Bertino J.R. Effect of codon 22 mutations on substrate and inhibitor binding for human dihydrofolate reductase. Adv. Exp. Med. Biol. 338 (1993) 515-519
41. Ercikan-Abali E.A., Banerjee D., Waltham M.C., Skacel N., Scotto K.W., and Bertino J.R. Dihydrofolate reductase protein inhibits its own translation by binding to dihydrofolate reductase mRNA sequences within the coding region. Biochemistry 36 (1997) 12317-12322
42. Farnham P.J., and Means A.L. Sequences downstream of the transcription initiation site modulate the activity of the murine dihydrofolate reductase promoter. Mol. Cell. Biol. 10 (1990) 1390-1398
43. Fry C.J., Pearson A., Malinowski E., Bartley S.M., Greenblatt J., and Farnham P.J. Activation of the murine dihydrofolate reductase promoter by E2F1. A requirement for CBP recruitment. J. Biol. Chem. 274 (1999) 15883-15891
44. Fujii H., and Shimada T. Isolation and characterization of cDNA clones derived from the divergently transcribed gene in the region upstream from the human dihydrofolate reductase gene. J. Biol. Chem. 264 (1989) 10057-10064
45. Futterman S. Enzymatic reduction of folic acid and dihydrofolic acid to tetrahydrofolic acid. J. Biol. Chem. 228 (1957) 1031-1038
46. Gee J.E., Blume S., Snyder R.C., Ray R., and Miller D.M. Triplex formation prevents Sp1 binding to the dihydrofolate reductase promoter. J. Biol. Chem. 267 (1992) 11163-11167
47. Gellekink H., Blom H.J., van der Linden I.J., and den Heijer M. Molecular genetic analysis of the human dihydrofolate reductase gene: Relation with plasma total homocysteine, serum and red blood cell folate levels. Eur. J. Hum. Genet. 15 (2007) 103-109
48. Goto Y., Yue L., Yokoi A., Nishimura R., Uehara T., Koizumi S., and Saikawa Y. A novel single-nucleotide polymorphism in the 3′-untranslated region of the human dihydrofolate reductase gene with enhanced expression. Clin. Cancer Res. 7 (2001) 1952-1956
49. Hammes-Schiffer S., and Benkovic S.J. Relating protein motion to catalysis. Annu. Rev. Biochem. 75 (2006) 519-541
50. Hillcoat B.L., Swett V., and Bertino J.R. Increase of dihydrofolate reductase activity in cultured mammalian cells after exposure to methotrexate. Proc. Natl. Acad. Sci. USA 58 (1967) 1632-1637
51. Hurford Jr. R.K., Cobrinik D., Lee M.H., and Dyson N. pRB and p107/p130 are required for the regulated expression of different sets of E2F responsive genes. Genes Dev. 11 (1997) 1447-1463
52. Johnson W.G., Stenroos E.S., Spychala J.R., Chatkupt S., Ming S.X., and Buyske S. New 19 bp deletion polymorphism in intron-1 of dihydrofolate reductase (DHFR): A risk factor for spina bifida acting in mothers during pregnancy?. Am. J. Med. Genet. A 124 (2004) 339-345
53. Johnson W.G., Scholl T.O., Spychala J.R., Buyske S., Stenroos E.S., and Chen X. Common dihydrofolate reductase 19-base pair deletion allele: A novel risk factor for preterm delivery. Am. J. Clin. Nutr. 81 (2005) 664-668
54. Lin S.Y., Black A.R., Kostic D., Pajovic S., Hoover C.N., and Azizkhan J.C. Cell cycle-regulated association of E2F1 and Sp1 is related to their functional interaction. Mol. Cell. Biol. 16 (1996) 1668-1675
55. Martianov I., Ramadass A., Serra Barros A., Chow N., and Akoulitchev A. Repression of the human dihydrofolate reductase gene by a non-coding interfering transcript. Nature 445 (2007) 666-670
56. Masters J.N., and Attardi G. The nucleotide sequence of the cDNA coding for the human dihydrofolic acid reductase. Gene 21 (1983) 59-63
57. Masters J.N., and Attardi G. Discrete human dihydrofolate reductase gene transcripts present in polysomal RNA map with their 5′ ends several hundred nucleotides upstream of the main mRNA start site. Mol. Cell. Biol. 5 (1985) 493-500
58. Masters J.N., Yang J.K., Cellini A., and Attardi G. A human dihydrofolate reductase pseudogene and its relationship to the multiple forms of specific messenger RNA. J. Mol. Biol. 167 (1983) 23-36
59. Maurer B.J., Barker P.E., Masters J.N., Ruddle F.H., and Attardi G. Human dihydrofolate reductase gene is located in chromosome 5 and is unlinked to the related pseudogenes. Proc. Natl. Acad. Sci. USA 81 (1984) 1484-1488
60. Maurer B.J., Carlock L., Wasmuth J., and Attardi G. Assignment of human dihydrofolate reductase gene to band q23 of chromosome 5 and of related pseudogene psi HD1 to chromosome 3. Somat. Cell Mol. Genet. 11 (1985) 79-85
61. Mayer-Kuckuk P., Banerjee D., Malhotra S., Doubrovin M., Iwamoto M., Akhurst T., Balatoni J., Bornmann W., Finn R., Larson S., Fong Y., Gelovani Tjuvajev J., et al. Cells exposed to antifolates show increased cellular levels of proteins fused to dihydrofolate reductase: A method to modulate gene expression. Proc. Natl. Acad. Sci. USA 99 (2002) 3400-3405
62. McPherson J.P., Saurbrey A., Meehl M., Russo A., Skacel N., and Bertino J.R. Characterization of RNA binding by mutant variants of human dihydrofolate reductase. Proc. Am. Assoc. Cancer Res. 40 (1999) 676a
63. Mishra P.J., Longo G.S.A., Menon L.G., Abali E.E., Humeniuk R., Cole P.D., Kamen B.A., Banerjee D., and Bertino J.R. The 829C→T single nucleotide polymorphism in the 3′ UTR of the dihydrofolate reductase gene results in methotrexate resistance and is rare among non-Japanese American patients. AACR Meeting Abstracts Vol. 301 (2006)
64. Mishra P.J., Humeniuk R., Longo-Sorbello G.S., Banerjee D., and Bertino J.R. A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance. Proc. Natl. Acad. Sci. USA 104 (2007) 13513-13518
65. Mitchell P.J., Carothers A.M., Han J.H., Harding J.D., Kas E., Venolia L., and Chasin L.A. Multiple transcription start sites, DNase I-hypersensitive sites, and an opposite-strand exon in the 5′ region of the CHO dhfr gene. Mol. Cell. Biol. 6 (1986) 425-440
66. Murchison E.P., and Hannon G.J. miRNAs on the move: miRNA biogenesis and the RNAi machinery. Curr. Opin. Cell Biol. 16 (2004) 223-229
67. Nevins J.R. The Rb/E2F pathway and cancer. Hum. Mol. Genet. 10 (2001) 699-703
68. Noe V., Alemany C., Chasin L.A., and Ciudad C.J. Retinoblastoma protein associates with SP1 and activates the hamster dihydrofolate reductase promoter. Oncogene 16 (1998) 1931-1938
69. Noe V., MacKenzie S., and Ciudad C.J. An intron is required for dihydrofolate reductase protein stability. J. Biol. Chem. 278 (2003) 38292-38300
70. Olney J.W., Fuller T.A., and de Gubareff T. Kainate-like neurotoxicity of folates. Nature 292 (1981) 165-167
71. Osborn M.J., and Huennekens F.M. Enzymatic reduction of dihydrofolic acid. J. Biol. Chem. 233 (1958) 969-974
72. Padmanabhan R., and Shafiullah M.M. Amelioration of sodium valproate-induced neural tube defects in mouse fetuses by maternal folic acid supplementation during gestation. Congenit. Anom. (Kyoto) 43 (2003) 29-40
73. Park K.K., Rue S.W., Lee I.S., Kim H.C., Lee I.K., Ahn J.D., Kim H.S., Yu T.S., Kwak J.Y., Heintz N.H., Magae J., and Chang Y.C. Modulation of Sp1-dependent transcription by a cis-acting E2F element in dhfr promoter. Biochem. Biophys. Res. Commun. 306 (2003) 239-243
74. Parle-McDermott A., Pangilinan F., Mills J.L., Kirke P.N., Gibney E.R., Troendle J., O'Leary V.B., Molloy A.M., Conley M., Scott J.M., and Brody L.C. The 19-bp deletion polymorphism in intron-1 of dihydrofolate reductase (DHFR) may decrease rather than increase risk for spina bifida in the Irish population. Am. J. Med. Genet. A 143 (2007) 1174-1180
75. Pemov A., Bavykin S., and Hamlin J.L. Proximal and long-range alterations in chromatin structure surrounding the Chinese hamster dihydrofolate reductase promoter. Biochemistry 34 (1995) 2381-2392
76. Perez-Lezaun A., Calafell F., Mateu E., Comas D., and Bertranpetit J. Identification of a base pair substitution at the tetranucleotide tandem repeat locus DHFRP2 (AAAC)n in a worldwide survey. Int. J. Legal Med. 109 (1996) 159-160
77. Polymeropoulos M.H., Xiao H., Rath D.S., and Merril C.R. Tetranucleotide repeat polymorphism at the human dihydrofolate reductase psi-2 pseudogene (DHFRP2). Nucleic Acids Res. 19 (1991) 4792
78. Rhoads G.G., and Mills J.L. Can vitamin supplements prevent neural tube defects? Current evidence and ongoing investigations. Clin. Obstet. Gynecol. 29 (1986) 569-579
79. Roberts C.W., and Orkin S.H. The SWI/SNF complex-Chromatin and cancer. Nat. Rev. Cancer 4 (2004) 133-142
80. Rossmann M.G., Moras D., and Olsen K.W. Chemical and biological evolution of nucleotide-binding protein. Nature 250 (1974) 194-199
81. Sawaya M.R., and Kraut J. Loop and subdomain movements in the mechanism of Escherichia coli dihydrofolate reductase: Crystallographic evidence. Biochemistry 36 (1997) 586-603
82. Schilling L.J., and Farnham P.J. Transcriptional regulation of the dihydrofolate reductase/rep-3 locus. Crit. Rev. Eukaryot. Gene Expr. 4 (1994) 19-53
83. Schnell J.R., Dyson H.J., and Wright P.E. Structure, dynamics, and catalytic function of dihydrofolate reductase. Annu. Rev. Biophys. Biomol. Struct. 33 (2004) 119-140
84. Shimada T., Chen M.J., and Nienhuis A.W. A human dihydrofolate reductase intronless pseudogene with an Alu repetitive sequence: Multiple DNA insertions at a single chromosomal site. Gene 31 (1984) 1-8
85. Shimada T., Inokuchi K., and Nienhuis A.W. Chromatin structure of the human dihydrofolate reductase gene promoter. Multiple protein-binding sites. J. Biol. Chem. 261 (1986) 1445-1452
86. Shimada T., Inokuchi K., and Nienhuis A.W. Site-specific demethylation and normal chromatin structure of the human dihydrofolate reductase gene promoter after transfection into CHO cells. Mol. Cell. Biol. 7 (1987) 2830-2837
87. Shinya E., and Shimada T. Identification of two initiator elements in the bidirectional promoter of the human dihydrofolate reductase and mismatch repair protein 1 genes. Nucleic Acids Res. 22 (1994) 2143-2149
88. Shrimpton P., Mullaney A., and Allemann R.K. Functional role for Tyr 31 in the catalytic cycle of chicken dihydrofolate reductase. Proteins 51 (2003) 216-223
89. Skacel N., Menon L.G., Mishra P.J., Peters R., Banerjee D., Bertino J.R., and Abali E.E. Identification of amino acids required for the functional up-regulation of human dihydrofolate reductase protein in response to antifolate Treatment. J. Biol. Chem. 280 (2005) 22721-22731
90. Slansky J.E., and Farnham P.J. Transcriptional regulation of the dihydrofolate reductase gene. Bioessays 18 (1996) 55-62
91. Slansky J.E., Li Y., Kaelin W.G., and Farnham P.J. A protein synthesis-dependent increase in E2F1 mRNA correlates with growth regulation of the dihydrofolate reductase promoter. Mol. Cell. Biol. 13 (1993) 1610-1618
92. Sowers R., Toguchida J., Qin J., Meyers P.A., Healey J.H., Huvos A., Banerjee D., Bertino J.R., and Gorlick R. mRNA expression levels of E2F transcription factors correlate with dihydrofolate reductase, reduced folate carrier, and thymidylate synthase mRNA expression in osteosarcoma. Mol. Cancer Ther. 2 (2003) 535-541
93. Tai N., Ding Y., Schmitz J.C., and Chu E. Identification of critical amino acid residues on human dihydrofolate reductase protein that mediate RNA recognition. Nucleic Acids Res. 30 (2002) 4481-4488
94. Tai N., Schmitz J.C., Chen T.M., and Chu E. Characterization of a cis-acting regulatory element in the protein-coding region of human dihydrofolate reductase mRNA. Biochem J. 378 (2004) 999-1006
95. Tsay J.T., Appleman J.R., Beard W.A., Prendergast N.J., Delcamp T.J., Freisheim J.H., and Blakley R.L. Kinetic investigation of the functional role of phenylalanine-31 of recombinant human dihydrofolate reductase. Biochemistry 29 (1990) 6428-6436
96. Tunnicliff G., and Ngo T.T. Folic acid and the inhibition of brain L-glutamic decarboxylase. Experientia 33 (1977) 67-68
97. van der Linden I.J., Nguyen U., Heil S.G., Franke B., Vloet S., Gellekink H., Heijer M., and Blom H.J. Variation and expression of dihydrofolate reductase (DHFR) in relation to spina bifida. Mol. Genet. Metab. 91 (2007) 98-103
98. Wald D.S., Law M., and Morris J.K. Homocysteine and cardiovascular disease: Evidence on causality from a meta-analysis. BMJ 325 (2002) 1202
99. Watanabe A., Ikejima M., Suzuki N., and Shimada T. Genomic organization and expression of the human MSH3 gene. Genomics 31 (1996) 311-318
100. Wright A.J., Dainty J.R., and Finglas P.M. Folic acid metabolism in human subjects revisited: Potential implications for proposed mandatory folic acid fortification in the UK. Br. J. Nutr. 98 (2007) 667-675
101. Xu X., Gammon M.D., Wetmur J.G., Rao M., Gaudet M.M., Teitelbaum S.L., Britton J.A., Neugut A.I., Santella R.M., and Chen J. A functional 19-base pair deletion polymorphism of dihydrofolate reductase (DHFR) and risk of breast cancer in multivitamin users. Am. J. Clin. Nutr. 85 (2007) 1098-1102
102. Zhang K., and Rathod P.K. Divergent regulation of dihydrofolate reductase between malaria parasite and human host. Science 296 (2002) 545-547